|
In the spotlight
Telescope Therapeutics joins the adMare Tx Accelerator
We are delighted to welcome Telescope Therapeutics, an Innovation Center's resident company, to the Accelerator Tx adMare.
Montreal Innovation Centre events
Lunch & Learn with CASTL
GMP Essentials for (Bio)Pharmaceuticals
Date : December 12 | 12:30 p.m. ET
Location : Philippe Walker Amphitheatre and on Zoom
A look back at the LSEDP Lunch & Learn
If you missed the Lunch & Learn on the Life Sciences Entrepreneurship Development Program and are interested in entrepreneurship, read the presentation below.
Are you looking to welcome an intern into your laboratories?
Discover the University of British Columbia's Pharmaceutical Sciences program and gain access to highly qualified and motivated students with expertise in drug discovery and development to support your R&D work.
Ecosystem events
Life Sciences BC's Holiday Party
Date: December 18, 2024
Location : Vancouver, BC
43rd Annual J.P. Morgan Healthcare Conference
Date: January 13-16, 2025
Location: San Francisco, CA
2025 OBIO® Investment Summit
Date : February 13-15, 2025
Location : Toronto, ON
Effervescence 2025
Applications are now open for the various competitions, including the start-up pitch competition.
Apply now!
News
News from our resident companies
Bioauxilium has added new assay kits to its catalog
A retrospective on the great success of CERASP's technology event!
Congruence and Ono announced multi-target research collaboration to generate small molecule correctors for the treatment of cancer
Cura Therapeutics presented at several events
Cura was one of the five companies selected to present to Life Science Angels at the BerkeleySkyDeck@LSA event.
Cura gave a presentation at the ACT Consortium's third annual meeting in Quebec City.
CXC is proud to financially support ECODA in its Oilseeds research
Defence Therapeutics announced extension of private placement, and continues development of Its radiopharmaceuticals and Adc programs
Domain Therapeutics nominated for the prestigious Prix Galien USA 2024
enGene announced $60 million private placement financing
Detalimogene demonstrates 71% complete response rate in preliminary analysis of LEGEND pivotal cohort
Investissement Québec supports Find Therapeutics
FDA clears Find's IND for Phase 1 study of FTX-101
NanoVation Therapeutics announced expansion of Board of Directors & completion of funding round led by Convergent Ventures
NanoVation announced multi-target partnership with Novo Nordisk to develop genetic medicines targeting cardiometabolic and rare diseases
Repare Therapeutics announced agreement with the US National Cancer Institute to advance the development of camonsertib
Repare Therapeutics announced updated positive safety and tolerability results from the Phase 1 MYTHIC clinical trial
Reverb Therapeutics to collaborate with Royalmount Laboratories on development of advanced bispecific antibodies
SeraGene Therapeutics has won two awards
SeraGene Therapeutics recognized as one of the Companies to Watch for 2024 at the 26th Life Sciences BC Awards.
SeraGene Therapeutics won the Coup de Coeur prize of $3,000 at the 4th edition of Sweet BioPharma Day.
Ventus Therapeutics announced successful completion of phase 1 clinical trial of VENT-03, a first-in-Class, orally administered cGAS inhibitor
adMare BioInnovations
Vancouver
2405 Wesbrook Mall
Vancouver, British Columbia, Canada
V6T 1Z3
Toronto
661 University Ave., Suite 405
Toronto, Ontario, Canada
M5G 1M1, CA
Montréal
7171 Frederick-Banting
Montréal, Québec, Canada
H4S 1Z9
 |